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a b s t r a c t
Background: Cerebral microdialysis enables assessment of regional metabolic physiology
and provides biomarkers for clinical correlation in critical conditions, such as subarachnoid
hemorrhage (SAH). The aim of our current study was to investigate the correlation between
regional cerebral blood ﬂow and microdialysis parameters (glucose, lactate, glycerol, pyru-
vate concentrations, and lactate/pyruvate metabolic ratio) in patients with SAH.
Materials and methods: Twenty-one patients with SAH were enrolled in our retrospective
study. Cerebral blood ﬂow (CBF) based on thermal diffusion methodology, the thermal
coefﬁcient K, and microdialysis biochemical markers were recorded. The duration of the
brain monitoring was 10 days.
Results: Microdialysis glucose concentration was inversely related to the cerebral tempera-
ture and to the L/P ratio. Furthermore, it was positively correlated to all other microdialysis
parameters but glycerol. The K coefﬁcient was strongly and positively correlated with the
temperature and marginally with the CBF. The L/P ratio was positively correlated with
glycerol, while it was inversely correlated with the CBF. Patients who died had elevated L/P
ratio and K coefﬁcient compared to the survivors in our series.
Conclusions: Thermal conductivity coefﬁcient may change over time as cerebral injury
progresses and tissue properties alter. These alterations were found to be associated with
the microdialysis metabolite concentrations and the CBF itself. The microdialysis biochem-
ical indices of cell stress and death (glycerol, L/P ratio) were positively related to each other,
while the measured L/P metabolic ratio was higher among patients who died.
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Subarachnoid hemorrhage (SAH) accounts for 3% of all strokes,
and 5% of all stroke deaths [1]. It is estimated that over 25% of
potential life years lost secondary to stroke, may be attributed
to SAH [2]. Despite the great advances in the diagnosis of SAH,
mortality remains high (around 50%), while approximately one
third of survivors have an unfavorable neurological and
functional outcome [3]. Monitoring of cellular environment's
events has unveiled critical biochemical processes, and has
helped in predicting cerebral vasospasm, thus allowing early
intervention [4–6]. It is estimated that approximately 70% of
the patients with aneurysmal SAH develop angiographic
vasospasm, while extracellular alterations in glutamate,
lactate, lactate/pyruvate ratio, and glycerol concentrations
have been associated with delayed cerebral ischemia follow-
ing aSAH [4–6]. Microdialysis monitoring enables assessment
of regional cerebral metabolic physiology, and provides
biomarkers for clinical correlation [7,8]. Most available data
in the pertinent literature come from traumatic brain injury
(TBI) patients, however its utilization in the setting of aSAH
has also been demonstrated [9].
The purpose of our present study was to investigate the
correlation between cerebral blood ﬂow and microdialysis
parameters [glucose, lactate, glycerol, pyruvate values and
lactate/pyruvate ratio (L/P)] in patients with SAH.
2. Materials and methods
All patients with CT proven diagnosis of recent onset SAH,
with or without intraventricular hemorrhage (IVH), admitting
Glasgow Coma Scale (GCS) score ≤ 8, and undergoing invasive
multi-parametric microdialysis monitoring were considered
for enrollment in our retrospective clinical study, with
prospectively set criteria. The protocol of our current study
was approved by the Institutional Review Board. All the
patients' data were handled according to the Helsinki and the
HIPAA acts. A detailed written consent form was obtained by
each patient's next of kin, for participating in our study.
Our inclusion criteria were: CT proven SAH diagnosis of
recent onset (less than 24 h since symptoms started), GCS
score upon admission ≤8, age >18 years. Patients with age >80
years, brain dead patients, patients with impending brain
death, patients with abnormal clotting studies upon admis-
sion, patients with chronic renal failure, and patients with
known malignancy history were excluded from our study. Our
study covered a 5-year period (from 2009 to 2013).
Complete demographic data, family and detailed past
medical history of every patient were recorded at admission,
followed by a thorough neurological examination.
A total of 21 patients met our inclusion criteria, out of the
37 patients admitted during the same period with the
diagnosis of SAH in our institution. All patients were sedated,
intubated and mechanically ventilated. A minimally invasive,
multiparametric, neuromonitoring system was introduced
within the ﬁrst 8 h after admission to the ICU department. A
frontal burr hole was placed at Kocher's point under sterile
conditions, and a three way-bolt kit (Licox bolt kit, IntegraNeuroSciences, Plainsboro, NJ, USA) was inserted. This bolt kit
was used for insertion of: (a) an intracranial pressure (ICP)
measurement catheter (Codman microsensor kit, Codman,
Johnson & Johnson, MA, USA), (b) a brain tissue-oxygen
monitoring catheter (PbrO2 measuring catheter, Licox, Integra
NeuroSciences, Plainsboro, NJ, USA), and (c) a microdialysis
catheter (CMA 70 Brain Microdialysis Catheter, 10 mm mem-
brane length, 20 kDa cut off, CMA, Stockholm, Sweden). The
catheters were placed in the intact brain parenchyma, and
ipsilateral to the most prominent pathology area. The proper
catheter position was conﬁrmed with a brain CT scan, which
was obtained within 24 h following the catheter's implanta-
tion.
A second burr hole was placed approximately 1–1.5 cm
anteriorly to the previously described one, and was used for
inserting a Cerebral Blood Flow (CBF) catheter (QFlow 500
Perfusion Probe, Hemedex, Cambridge, MA, USA). This cathe-
ter is ﬂexible, biocompatible, and radio-opaque, of 1 mm
(3 French/19 gauge) diameter, which is inserted into the brain
parenchyma for measuring regional cerebral blood ﬂow. This
catheter is FDA approved for cerebral monitoring for up to
10-days. The distal tip of the catheter was tunneled subcuta-
neously and was secured with sutures, 3–4 cm distal to the
entry point, as to minimize the risk of infections. The data
obtained are displayed on a bedside monitoring device
(Bowman Perfusion Monitor, Hemedex, Cambridge, MA,
USA) on a real time basis. This monitoring system provides
CBF calculations by employing a thermal diffusion methodol-
ogy, as this is expressed by the following equation: CBF = K(1/
V – 1/V0), where CBF is expressed in ml/100 g/min, V is the
voltage gradient between the two electrodes, V0 is the voltage
gradient under zero ﬂow, and K constitutes a constant
representing the brain parenchyma thermal conductivity
[10]. Additionally Brain Water Content (BWC) data can be
extrapolated from the measurements. In our study BWC data
were provided by the Hemedex Company (Hemedex, Cam-
bridge, MA, USA).
The duration of this multi-parametric brain monitoring
was 10 days in all of our patients. After this period the
catheters were removed. In those patients that there was
indication for further ICP monitoring, this was performed by
inserting a new intraparenchymal ICP ﬁberoptic catheter. All
the obtained data, including ICP, brain temperature, concen-
trations of lactate, pyruvate, glucose, glycerol, and the L/P
ratio, as well as the CBF measurements, and the K coefﬁcient
were recorded and analyzed. Moreover, the Simpliﬁed Acute
Physiology Score II (SAPS II), and the Predicted Death Rate
(PDR) scores were calculated and recorded.
All patients were treated using a cerebral perfusion
pressure (CPP) guided protocol. The patients' outcome was
evaluated with the Glasgow Outcome Scale (GOS) score at
discharge, and then at 3 and 6 months post-discharge, via
either a detailed neurological examination in our outpatient
clinic, or via a telephone interview performed by one of the
residents of our neurosurgery department.
2.1. Statistical analysis
The statistical analysis was performed using the program SPSS
22.0v. (Statistical Package for Social Sciences, IBM, Chicago, IL,
Table 1 – Demographic characteristics, SAPS II, and PDR scores of our patients.
Variable N (%) Mean  Std. deviation
Gender Female 7 (33.3)
Male 14 (66.6)
Outcome Death 8 (38.1%)
Survival 13 (61.9)
Operations performed Clipping 6 (28.6)
Coiling 4 (19.0)
Craniectomy (decompressive) 8 (38.1)
Ventricular drain 15 (71.4)
Modiﬁed Fisher scale Grade 3 6 (28.6)
Grade 4 15 (71.4)
Mortality Brain death
-Rebleeding




Multi-organ failure (due to sepsis) 3 (14.3)
Age 48.05  15.9
SAPS II 51.14  14.13
PDR 49.60  24.96
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and then were transferred to SPSS for further processing.
Normality was checked by Shapiro–Wilk test. Student's t test
was used for comparisons between groups. Generalized
Estimating Equations (GEE) was applied to continuous vari-
ables in order to handle repeated observations within subjects.
Repeated, real time, Hemedex values were analyzed on hourly
intervals, in accordance to microdialysis data. Statistical
signiﬁcance was set at p = 0.05.
3. Results
Our study population comprised of 21 patients (14 males and 7
females). The mean age was 48.05  15.93 years, while their
age spectrum was 18–73 years. The observed mortality rate in
our series was 38% (8/21 patients) (Table 1). Calculated SAPS II
were 51.14  14.12, while the PDR scores were 49.60  24.96
(Table 1).
Fourteen patients underwent brain surgery [clipping: 8 out
of 21 (38.1%), coiling: 4 out of 21 (19.0%)]. Eight patients
underwent craniectomy while ﬁfteen patients were subjected
to ventriculostomy as well. Five of the patients died because of
the primary neurological insult (brain death preceded) while
two of them suffered a fatal rebleeding incident. The cause of
mortality for the remaining three patients was multiorgan
failure because of sepsis. All patients were classiﬁed as grade 3
or 4 on the modiﬁed Fisher scale (Thick focal or diffuse SAH
with or without IVH).1
Regarding our multiparametric monitoring parameters,
none the differences observed reached the levels of statistical
signiﬁcance. The intraparenchymal cerebral temperature was
found to be higher in survivors than in patients who died
(36.83 8C vs. 36.48 8C, p = 0.248). Likewise, CBF was also
observed to be higher in survivors than in patients who died
(33.66 vs. 29.34 ml/100 g/min, p = 0.495). Additionally, lactate1 Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R,
Connolly ES Jr, MacDonald RL, Mayer SA. Prediction of symptom-
atic vasospasm after subarachnoid hemorrhage: the modiﬁed
ﬁsher scale. Neurosurgery. 2006;59(1):21–7.values were found to be higher in survivors than in patients
who did not survive (8.52 vs. 5.89 mmol/lit, p = 0.498).
Contrariwise, glucose, glycerol and pyruvate were found in
higher concentrations in non-survivors compared to patients
who survived (1.18 vs. 0.99 mmol/lit, 122.92 vs. 92.29 mmol/lit,
and 124.47 vs. 112.06 mmol/lit; p = 0.414, p = 0.488 and
p = 0.348, respectively). The largest differences were observed
in the L/P ratio, and the K coefﬁcient. In particular, patients
who died had an elevated L/P ratio and K coefﬁcient in
comparison with the survivors (L/P: 50.01  24.79 vs. 39.36
 9.57, p = 0.176; K: 3.34  0.69 vs. 3.02  0.35, p = 0.167
respectively). Regarding Brain Water Content, only two
patients had a mean BWC lower than 70.2% which is
considered within the normal range [11].
Further analysis of our dataset demonstrated that glucose
was inversely related to the cerebral temperature and to the
L/P ratio, while it was positively correlated to the K coefﬁcient,
the CBF, and all the microdialysis parameters with the
exception of glycerol. The observed concentrations of glycerol,
and the lactate were inversely correlated with the obtained
CBF measurements. The L/P ratio was positively correlated
with glycerol, and inversely correlated with CBF (Table 2).
When the GEE model was applied to K estimation, the K
coefﬁcient was correlated with glucose, pyruvate, marginally
and positively to CBF, while it was strongly and positively
correlated with the cerebral temperature (Table 3). CBF was
inversely related to BWC (r = 0.086, p < 0.001).
4. Discussion
Analysis of our current results demonstrated that the
microdialysis biochemical indices of cell stress and death
(glycerol, L/P) were positively related to each other, while the
observed L/P metabolic ratio was higher among patients who
died. The unfavorable prognosis in patients with high L/P ratio
and low CBF is well documented in the literature. In the study
by Bouzat et al., comatose patients demonstrated signiﬁcantly
higher average L/P ratios ( p < 0.02) [7]. In the same study, low
regional cerebral blood ﬂow correlated with increased intra-
cranial pressure (higher than 20 mm Hg), brain tissue PO2 less
Table 2 – Correlation between cerebral blood flow and the microdialysis measured cerebral parameters.
Pyr Glyc Lac CBF K T L/P
Glu r 0.382** 0.007 0.179** 0.117** 0.140** 0.219** 0.068**
p <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.001
Pyr r 0.178** 0.637** 0.180** 0.160** 0.428** 0.099**
p 0.019 <0.001 <0.001 <0.001 <0.001 <0.001
Glyc r 0.587** 0.134** 0.009 0.130** 0.447**
p <0.001 <0.001 0.567 <0.001 <0.001
Lac r 0.026 0.016 0.269** 0.464**
p 0.112 0.330 <0.001 <0.001
CBF r 0.235** 0.198** 0.047**
p <0.001 <0.001 0.003




* Correlation is signiﬁcant at the 0.05 level (2-tailed).
** Correlation is signiﬁcant at the 0.01 level (2-tailed).
Glu: glucose; Pyr: pyruvate; Glyc: glycerol; Lac: lactate; CBF: cerebral blood ﬂow.
L/P: lactate/pyruvate ratio; T: temperature; K: coefﬁcient (thermal conductivity).
Table 3 – GEE model for K coefficient.
Parameter B 95% Wald conﬁdence
interval
p Exp(B) 95% Wald conﬁdence
interval for Exp(B)
Lower Upper Lower Upper
(Intercept) 87.264 137.577 36.950 0.001 1.264E38 1.782E60 8.968E17
Glycerol 0.004 0.014 0.006 0.458 0.996 0.986 1.006
Pyruvate 0.044 0.086 0.003 0.037 0.957 0.917 0.997
Lactate 1.188 0.081 2.458 0.067 3.282 0.922 11.681
L/P 0.006 0.034 0.021 0.647 0.994 0.966 1.021
Glucose 3.294 0.904 5.684 0.007 26.943 2.469 294.058
Temp 2.967 1.627 4.306 <0.001 19.425 5.090 74.135
CBF 0.108 0.002 0.214 0.046 1.114 1.002 1.239
Dependent variable: K.
Statistically signiﬁcant associations in bold.
Model: (Intercept), glycerol, pyruvate, lactate, L/P, Glucose, temp, CBF.
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1 mmol/L, and L/P ratio more than 40 [7].
Moreover, the K coefﬁcient (related to thermal conductivity)
seems to be susceptible to changes, associated with metabolite
concentrations (as these were measured by microdialysis), and
even by the CBF itself. These changes were minimal in our
series, but they cannot be ignored, raising thus, questions
about the interpretation of CBF monitoring based on the
thermal conductivity. Tissue damage may be reﬂected on the K
value, through changes in tissue conductivity, which further
inﬂuences the CBF. The extracellular milieu of brain tissue
contains ions, metabolic substrates and neuroactive com-
pounds, which dynamically change during brain activity and
tissue repairing process [12]. This content alteration can
signiﬁcantly inﬂuence, not only the transmission of signal
information in the nervous tissue, but also tissue perfusion.
These two parameters are interrelated, as neuronal tissue
viability depends on the CBF [13].
Experimental data, obtained from a study in the rat brain,
showed that proteinosynthesis begins to be inhibited at ﬂow
rates below 55 ml/100 ml/min, while lactate accumulation
increase at ﬂow rates below 35 ml/100 g/min [14]. It has beenfound that CBF correlates best with glutamate, followed by
glycerol, whereas the L/P ratio is affected only after longer
periods of ischemia [15]. Low global CBF has been accompanied
by metabolic disturbances, which were accurately determined
by microdialysis [16]. It seems that a cerebral vascular event,
may lead the brain to a state of persistent metabolic crisis, as
this is reﬂected by abnormal cerebral microdialysis, which is
not related to the ischemia itself [17]. Regarding the correlation
between the CBF and the cerebral temperature, the mean
cerebral blood ﬂow (CBF) in patients with cerebral temperature
between 36.0 8C and 37.5 8C was 37.8  14.0 ml/100 g/min. The
lowest CBF (17.1  14.0 ml/100 g/min) has been measured in
patients with a cerebral temperature <36.0 8C [18]. The linearity
of correlation between the CBF and the cerebral temperature
was also conﬁrmed by our current data.
Interestingly, the results of our present study raise the issue
of the interpretation of CBF calculation, as the K coefﬁcient
appears to be ﬂuctuating. The observed K ﬂuctuation depends
on the brain parenchyma properties, which may alter over
time, as patient's condition changes. The K coefﬁcient
represents a tissue thermal conductivity constant, which is
dependent on the type of the tissue, its histological structure,
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temperature is considered as a rather stable characteristic
of mammalian tissues, and its relation to tissue content is well
established, it may well change when tissue content changes.
This change occurs in cerebral events, where the proportions
of blood and cell membranes are dynamically and constantly
rearranged.
This fact had been noticed by Ponder, who conducted
experiments with canine brain, lung, liver, muscle, and blood
samples, in both homogenized and en block forms [19]. It was
found that high lipid content (e.g. in brain tissue) accounts
for low K values, and even subtle differences in tissue
consistency may result into surprisingly large changes in
thermal conductivity [19]. Moreover, he reported that
homogenates may show smaller K values than blocks of
the same tissue, and this may be attributed to the different
heat propagation patterns, which structured tissue carries.
He postulated that the heat could be propagated better along
structured pathways than in homogenates, where the cyto-
architecture and the membranous structures have been
destroyed [19]. In that context, it is possible that changes in
brain architecture may cause K alterations, which in turn
may affect the CBF calculation [19]. Indeed, our present study
supports the idea that a linear relation between the K factor
and the microdialysis-measured parameters may exist.
Severe cerebral tissue damage may cause deviation of the
theoretically calculated K values, used in the interpretation
of the CBF. This ﬁnding may have clinical implications,
especially when BWC calculations and estimation of brain
edema take place.
There are confounding factors weakening the strength of
our conclusions. Firstly, we did not use an imaging technique
for measuring CBF such as CT perfusion or MR diffusion. In this
regard, we were not able to verify the recorded ﬂuctuations of
the measured CBF with another methodology. The rather
small size of our study population also affects the statistical
power of our results. Furthermore, the heterogeneity of our
study population does not allow deﬁnite conclusions to be
drawn, especially on the kind of the relation and the
mathematical equation between the K alteration and the
measured CBF values. BWC has been calculated according to
existing formulas. However, since only 2 of the patients had
brain water content less than 70% (considered low), further
analysis might have been statistically weak.
In conclusion, our current study underlines the fact that
biochemical indices of cell stress and death (glycerol, L/P) are
positively related to one another, while K values should not be
considered as constant as previously thought, especially in
patients in critical condition. Our current data clearly
demonstrate that K coefﬁcient may well change as brain
damage progresses, and tissue properties alter. Furthermore,
clinicians should be aware of this complex relationship
between the K coefﬁcient and the CBF measurements for
accurately interpreting all the monitoring parameters and
adjusting their patient management accordingly.
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